Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Authors
Keywords
-
Journal
Pharmacology Research & Perspectives
Volume 11, Issue 2, Pages -
Publisher
Wiley
Online
2023-02-22
DOI
10.1002/prp2.1063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association between statin use and Parkinson's disease in Korean patients with hyperlipidemia
- (2022) Ji Hee Kim et al. PARKINSONISM & RELATED DISORDERS
- Association between Statin Use and Risk of Parkinson’s Disease: Evidence from 18 Observational Studies Comprising 3.7 Million Individuals
- (2022) Chieh-Chen Wu et al. Journal of Personalized Medicine
- Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
- (2022) Kara N. Stevens et al. JAMA Neurology
- Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
- (2022) Nawal Alsubaie et al. Brain Sciences
- A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
- (2022) Hayder M. Al-Kuraishy et al. NEUROCHEMICAL RESEARCH
- Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects
- (2022) Hayder M. Al-kuraishy et al. INFLAMMOPHARMACOLOGY
- Prodromal Parkinson disease subtypes — key to understanding heterogeneity
- (2021) Daniela Berg et al. Nature Reviews Neurology
- Effects of statins on dopamine loss and prognosis in Parkinson’s disease
- (2021) Seong Ho Jeong et al. BRAIN
- A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson’s Disease
- (2021) Anna Pierzchlińska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019
- (2021) Zejin Ou et al. Frontiers in Public Health
- The Role of Lipids in Parkinson’s Disease
- (2019) Helena Xicoy et al. Cells
- HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells
- (2019) Dan Lu et al. NEURAL PLASTICITY
- Brain cholesterol metabolism and Parkinson's disease
- (2019) Xuemei Huang et al. MOVEMENT DISORDERS
- Effect of statins on Parkinsonʼs disease
- (2019) Junqiang Yan et al. MEDICINE
- Association of statin use with Parkinson's disease: Dose–response relationship
- (2019) Su‐Min Jeong et al. MOVEMENT DISORDERS
- Parkinson’s Disease in Women and Men: What’s the Difference?
- (2019) Silvia Cerri et al. Journal of Parkinsons Disease
- Lipids, Apolipoproteins, and the Risk of Parkinson Disease
- (2019) Fang Fang et al. CIRCULATION RESEARCH
- The genetic architecture of Parkinson's disease
- (2019) Cornelis Blauwendraat et al. LANCET NEUROLOGY
- Trends in the incidence and prevalence of Parkinson’s disease in Korea: a nationwide, population-based study
- (2019) Joo-Hyun Park et al. BMC Geriatrics
- Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
- (2019) Uram Jin et al. Experimental Neurobiology
- The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review
- (2019) Hossein Bagheri et al. BIOFACTORS
- Basal ganglia and beyond: The interplay between motor and cognitive aspects in Parkinson’s disease rehabilitation
- (2018) Davide Ferrazzoli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Age-related selection bias in Parkinson's disease research: are we recruiting the right participants?
- (2018) Angus D. Macleod et al. PARKINSONISM & RELATED DISORDERS
- Neuropathology of Parkinson disease
- (2018) Dennis W. Dickson PARKINSONISM & RELATED DISORDERS
- Higher serum cholesterol and decreased Parkinson's disease risk: A statin-free cohort study
- (2018) Violetta Rozani et al. MOVEMENT DISORDERS
- Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson’s Disease Dementia
- (2018) Suisui Pang et al. Parkinsons Disease
- Impact of high cholesterol in a Parkinson’s disease model: Prevention of lysosomal leakage versus stimulation of α-synuclein aggregation
- (2017) Ida Eriksson et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database
- (2017) Guodong Liu et al. MOVEMENT DISORDERS
- Neuropathological Staging of Brain Pathology in Sporadic Parkinson’s disease: Separating the Wheat from the Chaff
- (2017) Heiko Braak et al. Journal of Parkinsons Disease
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Statin therapy prevents the onset of Parkinson disease in patients with diabetes
- (2016) Kun-Der Lin et al. ANNALS OF NEUROLOGY
- Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis
- (2016) Katsiaryna Bykov et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line
- (2016) Mathieu Schmitt et al. SYNAPSE
- The role of mitochondria in statin-induced myopathy
- (2015) Maria Apostolopoulou et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effects of simvastatin on the expression of inducible nitric oxide synthase and brain-derived neurotrophic factor in a lipopolysaccharide-induced rat model of Parkinson disease
- (2015) Wang Tan et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Effect of Cholesterol Reduction on Receptor Signaling in Neurons
- (2015) Kenji Fukui et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cholesterol – A putative endogenous contributor towards Parkinson's disease
- (2015) Rajib Paul et al. NEUROCHEMISTRY INTERNATIONAL
- Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies
- (2015) Keiko Nakamura et al. NEUROPATHOLOGY
- Relationship between Cognitive Performance and Motor Dysfunction in Patients with Parkinson’s Disease: A Pilot Cross-Sectional Study
- (2015) Valentina Varalta et al. Biomed Research International
- The serum lipid profile of Parkinson's disease patients: a study from China
- (2014) Xiaoyan Guo et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Plasma apolipoprotein A1 as a biomarker for Parkinson disease
- (2013) Judy K. Qiang et al. ANNALS OF NEUROLOGY
- Discontinuation of statin therapy associates with Parkinson disease: A population-based study
- (2013) Y.-C. Lee et al. NEUROLOGY
- Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
- (2013) Ingemar Björkhem et al. NEUROSCIENCE LETTERS
- Prospective Study of Statin Use and Risk of Parkinson Disease
- (2012) Xiang Gao ARCHIVES OF NEUROLOGY
- Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients
- (2012) Dariusz Koziorowski et al. CYTOKINE
- Importance of cholesterol in dopamine transporter function
- (2012) Kymry T. Jones et al. JOURNAL OF NEUROCHEMISTRY
- Unknown
- (2011) Noemi Fabelo et al. MOLECULAR MEDICINE
- Prospects of Statins in Parkinson Disease
- (2011) Avik Roy et al. NEUROSCIENTIST
- Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
- (2011) Xuemei Huang et al. PLoS One
- Statins and the risk of Parkinson disease: an update on the controversy
- (2009) Claudia Becker et al. Expert Opinion On Drug Safety
- Dietary fat intake and risk of Parkinson's disease: A case-control study in Japan
- (2009) Yoshihiro Miyake et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- TOTAL CHOLESTEROL AND THE RISK OF PARKINSON DISEASE
- (2009) L. Mascitelli et al. NEUROLOGY
- Non-motor symptoms in Parkinson’s disease
- (2008) W. Poewe EUROPEAN JOURNAL OF NEUROLOGY
- Statin use and the risk of Parkinson disease
- (2008) A. D. Wahner et al. NEUROLOGY
- Total cholesterol and the risk of Parkinson disease
- (2008) G. Hu et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation